THE MECHANISM OF ADVERSE EVENTS ASSOCIATED WITH TERAZOSIN:
- 1 April 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- p. 1134-1137
- https://doi.org/10.1097/00005392-200004000-00016
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic HyperplasiaUrology, 1998
- Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow ratesUrology, 1997
- Prostatic α1-adrenoceptors and uroselectivityThe Prostate, 1997
- TamsulosinDrugs, 1996
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaNew England Journal of Medicine, 1996
- Prostate Selectivity of Alpha-Blockers: From Receptor Biology to Clinical MedicineEuropean Urology, 1996
- A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic HyperplasiaJournal of Urology, 1992